MedPath

Cardiac MRI findings of repaired tetralogy of Fallot: A meta-analysis

Not Applicable
Conditions
repaired tetralogy of Fallot
Registration Number
JPRN-UMIN000047579
Lead Sponsor
Yokohama City University
Brief Summary

Our meta-analysis showed a significant increase in LV-ECV among rTOF patients compared to control subjects (MD = 2.63, 95%CI: 1.35 to 3.90, p < 0.0001, I2 = 86%, p for heterogeneity < 0.00001). Moreover, RV-ECV was found to be substantially higher in patients compared to LV-ECV. Our meta-analysis also revealed a significant association between RV-ECV and adverse events (HR = 1.15, 95% CI: 1.04 to 1.27, p = 0.005, I2 = 0%, p for heterogeneity = 0.62).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
856
Inclusion Criteria

Not provided

Exclusion Criteria

N/A

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of abnormalities of CMR findings and impact on the prognosis in patients with rTOF.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath